1. Home
  2. VTRS vs TLN Comparison

VTRS vs TLN Comparison

Compare VTRS & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • TLN
  • Stock Information
  • Founded
  • VTRS 1961
  • TLN 2015
  • Country
  • VTRS United States
  • TLN United States
  • Employees
  • VTRS N/A
  • TLN N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • TLN Electric Utilities: Central
  • Sector
  • VTRS Health Care
  • TLN Utilities
  • Exchange
  • VTRS Nasdaq
  • TLN Nasdaq
  • Market Cap
  • VTRS 11.8B
  • TLN 12.7B
  • IPO Year
  • VTRS N/A
  • TLN N/A
  • Fundamental
  • Price
  • VTRS $10.61
  • TLN $377.82
  • Analyst Decision
  • VTRS Hold
  • TLN Strong Buy
  • Analyst Count
  • VTRS 5
  • TLN 12
  • Target Price
  • VTRS $10.40
  • TLN $298.08
  • AVG Volume (30 Days)
  • VTRS 9.5M
  • TLN 1.2M
  • Earning Date
  • VTRS 08-07-2025
  • TLN 08-07-2025
  • Dividend Yield
  • VTRS 4.52%
  • TLN N/A
  • EPS Growth
  • VTRS N/A
  • TLN N/A
  • EPS
  • VTRS N/A
  • TLN 3.80
  • Revenue
  • VTRS $14,115,700,000.00
  • TLN $2,128,000,000.00
  • Revenue This Year
  • VTRS N/A
  • TLN $9.26
  • Revenue Next Year
  • VTRS $1.85
  • TLN $42.30
  • P/E Ratio
  • VTRS N/A
  • TLN $99.35
  • Revenue Growth
  • VTRS N/A
  • TLN 1.09
  • 52 Week Low
  • VTRS $6.85
  • TLN $130.91
  • 52 Week High
  • VTRS $13.55
  • TLN $394.07
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 72.50
  • TLN 67.00
  • Support Level
  • VTRS $8.74
  • TLN $365.08
  • Resistance Level
  • VTRS $9.03
  • TLN $388.00
  • Average True Range (ATR)
  • VTRS 0.32
  • TLN 14.31
  • MACD
  • VTRS 0.17
  • TLN -2.18
  • Stochastic Oscillator
  • VTRS 90.83
  • TLN 58.69

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About TLN Talen Energy Corporation Common Stock

Talen Energy Corp is an independent power producer and energy infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.

Share on Social Networks: